Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2019 10:05 ET | Source: Abpro Therapeutics

Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies

Abpro eligible to receive up to $4 billion, including $60 million in near-term R&D funding, plus potential milestones and royaltiesCollaboration to result in multiple new immuno-oncology...